New Drugs
- Drug Development
through Partnership -
Celltrion is actively engaged in licensing in/out through strategic partnerships with the industry, academia, and research centers to expand its pipelines. Through these partnerships, we plan to boost the effectiveness of our new drug R&D projects and revitalize the bio ecosystems in and outside of Korea.
- CDMO
-
Contract Development and Management Organization (CDMO) is a co-development model where participants offer and share their expertise in development/production/clinical trial/approval and development costs. Our CDMO partners can commercialize candidate substances for new drugs faster by tapping into our capabilities while we enjoy the benefit of securing the rights to use the substances before others. All in all, CDMO promises faster and dynamic growth for all parties involved.
-
molecule -
-
-
manufacturing
-
IND packages -